Descemet stripping endothelial keratoplasty outcomes in patients with rheumatoid arthritis

dc.authorid0000-0002-4161-5293en_US
dc.contributor.authorÇınar, Yasin
dc.contributor.authorDelvadia, Bela
dc.contributor.authorŞahin, Alparslan
dc.contributor.authorHammersmith, Kristin M.
dc.contributor.authorNagra, Parveen K.
dc.contributor.authorRapuano, Christopher J.
dc.contributor.authorSyed, Zeba A.
dc.date.accessioned2022-12-20T07:07:19Z
dc.date.available2022-12-20T07:07:19Z
dc.date.issued2021en_US
dc.departmentDicle Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Göz Hastalıkları Ana Bilim Dalıen_US
dc.description.abstractPurpose: To review the graft and visual outcomes in a series of patients with rheumatoid arthritis (RA) who underwent Descemet stripping endothelial keratoplasty (DSEK). Methods: In this case series, the electronic medical records at Wills Eye Hospital were queried for cases of patients with RA who underwent DSEK between January 1, 2009 and September 1, 2018. Charts were reviewed to obtain demographic data, medical history, ocular history, surgical variables, graft survival, and visual acuity outcomes. Results: During the study period, 22 transplants performed in 18 eyes of 15 patients with RA were eligible for inclusion. The mean age at the time of initial DSEK was 70.5 +/- 11.1 years (range 46-87). The mean follow-up time for the included eyes was 4.89 +/- 2.71 years (range 1.95-10.39). The overall estimated graft survival was 8.26 +/- 0.81 years with a 5-year survival rate of 88.9%. A significant improvement from preoperative best corrected visual acuity (logarithm of the minimum angle of resolution 0.84, approximately 20/140) to the most recent follow-up (logarithm of the minimum angle of resolution 0.29, approximately 20/40) was noted (P < 0.001). Conclusions: In our case series, patients with a history of RA underwent successful DSEK with excellent graft survival rates and visual acuity outcomes. Well-controlled RA should therefore not be considered a deterrent to performing DSEK.en_US
dc.identifier.citationÇınar, Y., Delvadia, B., Şahin, A., Hammersmith, K.M., Nagra, P.K., Rapuano, C.J. ve diğerleri. (2021). Descemet stripping endothelial keratoplasty outcomes in patients with rheumatoid arthritis. Cornea, 40(8), 982-987.en_US
dc.identifier.doi10.1097/ICO.0000000000002504
dc.identifier.endpage987en_US
dc.identifier.issn0277-3740
dc.identifier.issn1536-4798
dc.identifier.issue8en_US
dc.identifier.pmid32947399
dc.identifier.scopus2-s2.0-85111789508
dc.identifier.scopusqualityQ1
dc.identifier.startpage982en_US
dc.identifier.urihttps://journals.lww.com/corneajrnl/Fulltext/2021/08000/Descemet_Stripping_Endothelial_Keratoplasty.8.aspx
dc.identifier.urihttps://hdl.handle.net/11468/11091
dc.identifier.volume40en_US
dc.identifier.wosWOS:000711685000008
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorÇınar, Yasin
dc.language.isoenen_US
dc.publisherLippincott William & Wilkinsen_US
dc.relation.ispartofCornea
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectDSEKen_US
dc.subjectGraft failureen_US
dc.subjectGraft survivalen_US
dc.subjectRheumatoid arthritisen_US
dc.titleDescemet stripping endothelial keratoplasty outcomes in patients with rheumatoid arthritisen_US
dc.titleDescemet stripping endothelial keratoplasty outcomes in patients with rheumatoid arthritis
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
Descemet Stripping Endothelial Keratoplasty Outcomes in Patients With Rheumatoid Arthritis.pdf
Boyut:
126.9 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: